← Back to Search

Stent Graft System

Valiant™Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysms

N/A
Waitlist Available
Led By Thomas Maldonado
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Saccular aneurysm deemed at significant risk for rupture
Proximal landing zone for the thoracic bifurcation stent graft that has:
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to year 1
Awards & highlights

Study Summary

This trial is testing whether the ValiantTM Visceral Manifold Thoracoabdominal Stent Graft System is safe and effective for the repair of thoracoabdominal aortic aneurysms.

Eligible Conditions
  • Thoracoabdominal Aortic Aneurysms

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have a bulging blood vessel in your brain that is at high risk of bursting.
Select...
The area where the stent graft needs to be placed in your body is too close to an important junction.
Select...
There needs to be enough space around the celiac artery for inserting a tube during the procedure, taking into account the distance from the access point and the length of the surrounding structures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to year 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to year 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Freedom from Major Adverse Events (MAE) at Day 30
Percentage of Participants with Treatment Success at Year 1
Secondary outcome measures
Freedom from Paraparesis at Day 30

Trial Design

2Treatment groups
Experimental Treatment
Group I: Primary Arm: Treatment with Valiant Thoracoabdominal Stent Graft SystemExperimental Treatment1 Intervention
The implantation of the Valiant Thoracoabdominal Stent Graft System is conducted under fluoroscopic/angiographic guidance.
Group II: Expanded Use Arm: Treatment with Valiant Thoracoabdominal Stent Graft SystemExperimental Treatment1 Intervention
The implantation of the Valiant Thoracoabdominal Stent Graft System is conducted under fluoroscopic/angiographic guidance.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Valiant™Thoracoabdominal Stent Graft System
2017
N/A
~20

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,359 Previous Clinical Trials
817,196 Total Patients Enrolled
Thomas MaldonadoPrincipal InvestigatorNYU Langone Health

Media Library

Valiant™Thoracoabdominal Stent Graft System (Stent Graft System) Clinical Trial Eligibility Overview. Trial Name: NCT03246126 — N/A
Thoracoabdominal Aortic Aneurysms Research Study Groups: Primary Arm: Treatment with Valiant Thoracoabdominal Stent Graft System, Expanded Use Arm: Treatment with Valiant Thoracoabdominal Stent Graft System
Thoracoabdominal Aortic Aneurysms Clinical Trial 2023: Valiant™Thoracoabdominal Stent Graft System Highlights & Side Effects. Trial Name: NCT03246126 — N/A
Valiant™Thoracoabdominal Stent Graft System (Stent Graft System) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03246126 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still welcome to join this experiment?

"The clinical trial was initially posted in November of 2017 and the most recent edit was done on 11/9/2022. It does not appear that this particular study is currently accepting candidates, however there are 152 other trials actively recruiting at present."

Answered by AI
~2 spots leftby Mar 2025